Chde Polska S.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-10-12
Share capital
24,845,746.00 PLN
Average employment (people)
63 (2025)
Activity description

CHDE Polska presents service information and support, including service requests, frequently asked questions, and instructions for Microlife and Pempa products. Its website also features information about the company’s R&D activities, alongside its service-related resources and product guidance.

Registered address
ul. Biesiadna 7, 35-304 Rzeszów, Poland
Branches
  • ul. Kasprzaka 54A, 41-303 Dąbrowa Górnicza
Website
Email
Phone
Social media

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)-$16,602
Profit allocationLoss covered
Capital expenditure$398,608
Planned capital expenditure (next year)$251,130
Revenue structureTowary
R&D costs$119,470

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 103 days for 2021). All were audited by a statutory auditor.

  • 202520/07/2026
  • 202410/07/2025
  • 202329/07/2024
  • 202214/07/2023
  • 202126/10/2022
  • 202011/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods181 / 1,136
Top 16%
Division · Wholesale trade1,727 / 20,037
Top 8.6%
City · Rzeszów102 / 3,762
Top 2.7%
Voivodeship · Podkarpackie387 / 10,779
Top 3.6%
Country · Poland11,971 / 297,069
Top 4.0%

Results vs industry

Revenue
This companyUSD 17.54mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD -60.67kMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 17.29mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 12.67mMedianUSD 610.11kAverageUSD 11.92m

Websites

  • WordPress 3.7ElementorNginx
  • pempa.plPEMPA – dystrybutor sprzętu medycznego: termometry, ciśnieniomierze, inhalatory
    WordPress 6.9ElementorGoogle AnalyticsGoogle Tag ManagerNginx
  • walidacjakliniczna.plCiśnieniomierze z walidacją kliniczną – Walidacja Kliniczna
    WordPress 3.7Google AnalyticsGoogle Tag ManagerYoast SEOApache

Public procurement

1 tender recorded as contractor, with a total value of $978.

SubjectAmount
Supply of medical equipment
$978

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2008. In 2017 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2017
Provision of medical devicespodkarpackie1USD 0.00

Trademarks

The company holds 3 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2010.

MarkNumberClassesStatusProtected until
GHMS Z.4549115, 10, 16, 38, 42, 44Protected Apr 15, 2036
Złoty Standard (word)Z.3815163, 10, 35Protected Feb 18, 2031
chde Z.3791883, 10, 35Protected Dec 20, 2030
chde NANOPOLYMERS Z.4622821, 3, 5, 10, 25, 31, 32Expired –
Złoty Standard (word)Z.4489405Expired –
MarkProtected until
GHMS Apr 15, 2036
Złoty Standard (word)Feb 18, 2031
chde Dec 20, 2030
chde NANOPOLYMERS –
Złoty Standard (word)–

Authorized Representatives

Jerzy Jeremi Żukowski age 55 – President of the Management Board
Tomasz Wiesław Żukowski age 49 – Management Board Member

Manner of representation

In the case of a one-person management board, a member of the management board is authorised independently to make declarations of will on behalf of the company. If the management board is a multi-member management board, the President of the Management Board is authorised independently to make declarations of will on behalf of the company, and in the case of the remaining members of the management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorised.

Supervisory board

Maksymilian Żukowski age 21 – Supervisory Board Member
Paweł Żukowski age 19 – Supervisory Board Member
Sebastian Zabłocki age 46 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2008-01-18.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$837.8K
Buildings and premises
$285.4K

Properties named as collateral

Nieruchomość w Dąbrowie Górniczej przy ul. Kasprzaka 54a

Secured liabilities

Type
Mortgage over real property
Registered pledge over inventory
Assignment of rights under the insurance policy

Public aid

15 public aid cases recorded, with a total value of $3,097,001.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

European Funds

ProjectEU co-financing
Working capital grant for CHDE POLSKA SPÓŁKA AKCYJNA
$21,247
Encapsulation as an innovative method of delivering lipophilic active substances in dietary supplements.
$639.4K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Miro P.S.A.
Novamed.Pl S.A.
EMS - Euromed Medical Solution sp. z o.o.
Camedica Paweł Harasimiuk sp. k.
Informer Med sp. z o.o.
Biomedica Poland sp. z o.o.
Medicom sp. z o.o.
Mindray Medical Poland sp. z o.o.
Polmil sp. z o.o.
Pempa Jerzy Żukowski sp. j.

FAQ

Last updated: 2026-10-02